Israel Englander Dia Medica Therapeutics Inc. Transaction History
Millennium Management LLC
- $175 Billion
- Q1 2025
A detailed history of Israel Englander (Millennium Management LLC) transactions in Dia Medica Therapeutics Inc. stock. As of the latest transaction made, Millennium Management LLC holds 336,880 shares of DMAC stock, worth $1.33 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
336,880
Previous 84,829
297.13%
Holding current value
$1.33 Million
Previous $448,000
184.82%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding DMAC
# of Institutions
64Shares Held
6.11MCall Options Held
14.9KPut Options Held
1K-
Vanguard Group Inc Valley Forge, PA1.35MShares$5.34 Million0.0% of portfolio
-
First Manhattan CO New York, NY606KShares$2.4 Million0.01% of portfolio
-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX600KShares$2.37 Million5.72% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA557KShares$2.2 Million0.0% of portfolio
-
Bleichroeder LP New York, NY382KShares$1.51 Million0.5% of portfolio
About DiaMedica Therapeutics Inc.
- Ticker DMAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,443,100
- Market Cap $104M
- Description
- DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...